“Domestic violence”: Parents stab child 17,000 times
Sensor-assisted pump therapy (SuP) has existed since 2006 by combining insulin pumps and continuous glucose monitoring, or CGM for short. While this new form of therapy is being prescribed to a much greater extent, especially for type 1 diabetics in other European countries, there is already general reimbursement in the Netherlands, Switzerland, Israel, Slovenia, Sweden, Ireland, Slovakia, Estonia and Austria exists, penetration in Germany is rather low. Because CGM is currently not reimbursable in this country - so each health insurance company decides on a case-by-case basis. On November 23rd last year, the G-BA commissioned IQWiG, which published a preliminary report plan on “Continuous glucose measurement with real-time measuring devices” on April 18th this year, which was published on July 20th after a hearing on July 9th. was finalized in October. This is now the basis of a preliminary assessment that will be published in the first quarter of 2014, which will then be submitted for hearing again. Only then – in the third quarter of next year – will the G-BA decide on reimbursement eligibility.
Read more
First publication date: 28.05.2013
Downloads
Additional Information
- Issue: Issue 06/2013 Publication Date: 28.05.2013 All issues as PDF Subscribe to print magazine Order single issue Open Access
